MetaCap

Ocular Therapeutix Statistics

NASDAQ: OCULHealth CareBiotechnology: Pharmaceutical PreparationsUSD

5.57-0.29 (-4.95%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ocular Therapeutix by the numbers

Ocular Therapeutix has a market capitalization of $1.23 billion based on 220.02M shares outstanding. With trailing EPS of $-1.44, Ocular Therapeutix is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.6% below its 50-day average and 36.9% below its 200-day average.

Average daily trading volume is 3.03M shares, or about $16.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

OCUL valuation vs. peer median

OCUL compared with the median of 8 peer companies
MetricOCULPeer medianDifference
Market cap$1.23B$1.23B-1%
Avg. volume3.03M857.37K+253%

Peer median across 8 companies: GENB, SLN, MNKD, MLYS, AMPH, GHRS, LBRX, AVLN.

Valuation

Price / sales (latest FY)
23.59
EPS (TTM)
$-1.44

Price and trading

Previous close
5.86
Open
5.76
Day range
5.54 – 5.95
52-week range
5.54 – 16.44
52-week change
-54.49%
Beta
—
Volume
2.89M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.23B
Forward Pe
-3.50
Eps
-1.44
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
16.44
Week52 Low
5.54
Avg Volume
3.03M
Shares Outstanding
220.02M
Ma50
7.49
Ma200
8.83
Earnings Date
Nov 9, 2026
Pct From52w High
-66.12%
Pct From52w Low
0.54%

Related